CJC-1295 (no DAC) Catalog Comparison Notes — this article examines published research context, laboratory applications, and procurement notes for CJC-1295 (no DAC) (5mg / 10mg) in Growth Research programs at Sulan Peptide Official.
CJC-1295 (no DAC), also known as modified GRF (1-29), is a synthetic GHRH analog peptide used in laboratory research on growth-hormone-axis signaling, receptor activation, and short-acting peptide analog behavior without DAC-mediated albumin binding.
Sulan Peptide presents CJC-1295 (no DAC) with clear product specifications, available vial formats, Cat No. details, and pricing references to help qualified buyers prepare structured quotation requests.
The no-DAC format is separated from CJC-1295 with DAC so buyers can compare research context, molecular data, and specification options without confusion between the two catalog items.
Laboratories preparing CJC-1295 (no DAC) protocols commonly pair the material with Sterile Bacteriostatic Water (BAC), Precision laboratory pipettes, Low-bind microtubes, Vial storage organizers (-20°C). These are workflow accessories—not bundled in the vial.
Research teams working with CJC-1295 (no DAC) often include Growth-axis research labs, GHRH pathway research teams, Short-acting peptide analog researchers, Preclinical peptide pharmacology groups, Qualified peptide procurement teams. These groups typically require documented peptide identity, batch COA review, and RUO compliance before releasing material into cell or animal protocols.
Structure–activity studies compare amino-acid substitutions at positions 1–29 for GHRH receptor selectivity versus other class B GPCRs.
Perifusion systems measuring GH burst amplitude and frequency are widely cited when evaluating non-DAC GHRH analogs.
Growth-axis research differentiates DAC and non-DAC formats when designing experiments that require discrete GH pulses versus sustained elevation models.
Modified GRF(1-29) without DAC preserves shorter half-life suitable for pulse-mimicking perfusion experiments on pituitary cells.
Catalog comparison: When evaluating CJC-1295 (no DAC) within Growth Research, compare vial format (5mg / 10mg), documented purity, and COA availability—not product names alone.
Related catalog items in the same research direction include CJC-1295 with DAC, CJC1295(no DAC)&IPA, HCG, HGH 191AA. Open parallel product tabs and export specification fields before leadership approval.
Blend kits versus single-peptide vials serve different experimental designs; confirm protocol requirements before selecting CJC-1295 (no DAC) over alternatives.
Published Growth Research papers often include positive and negative assay controls alongside CJC-1295 (no DAC); budget control compounds before ordering experimental material.
When designing multi-arm studies, randomize vial lot assignment and blind analysts to supplier identity until primary readouts are locked—this reduces bias in vendor comparison experiments involving CJC-1295 (no DAC).
Literature searches for CJC-1295 (no DAC) should use both trade names and CAS 863288-34-0 to capture mechanistic papers missed by supplier marketing keywords alone.
Pilot experiments with CJC-1295 (no DAC) often start at mid-range catalog specifications (5mg / 10mg) before scaling quantity for full study cohorts.
Cell viability panels should precede mechanism assays when introducing CJC-1295 (no DAC) to new cell lines—unexpected toxicity may reflect solvent choice rather than peptide sequence.
For long-horizon Growth Research projects, document freezer location and thaw count on every aliquot label tied to CJC-1295 (no DAC) lot numbers.
Appearance notes (White Lyophilized Powder) help detect moisture exposure or handling damage during receiving inspection of CJC-1295 (no DAC).
Internal IRB or IACUC protocols should cite RUO scope explicitly when CJC-1295 (no DAC) appears in animal or human-derived tissue research models.
Catalog specification data for CJC-1295 (no DAC) lists CAS 863288-34-0, Molecular formula C152H252N44O42. molecular weight 3367.9 g/mol, and purity target ≥ 99.0%. Match these identifiers to incoming COA documents and internal sample labels before assay use.
Supplier storage guidance for CJC-1295 (no DAC): Store at -20°C, in a cool and dry place. Log receipt date, lot number, and freezer location when material enters your inventory. Plan aliquots before reconstitution to limit freeze-thaw cycles during multi-week assay series.
Available CJC-1295 (no DAC) research formats on sulanpeptide.shop include 5mg10vials, 10mg10vials. Cat No. references (CND5, CND10) should appear on requisitions so quoted material matches the specification selected during protocol design.
Price-per-mg comparisons for CJC-1295 (no DAC) should include documentation and shipping costs, not vial price alone.
Dose–response studies with CJC-1295 (no DAC) typically span log-scale concentrations; your protocol should state whether dosing is by mass (5mg / 10mg) or molarity derived from molecular weight on the product page.
Compare published assay incubation times for CJC-1295 (no DAC); overnight versus short pulses can invert apparent potency rankings in receptor assays.
Purity target ≥ 99.0% on the catalog is a specification goal—your QA team should confirm the specific lot COA meets internal thresholds before release.
When CJC-1295 (no DAC) appears in combination with other peptides, cite each sequence’s Cat No. in publications to satisfy reproducibility standards in Growth Research journals.
Statistical plans should pre-register primary endpoints before unblinding CJC-1295 (no DAC) treatment arms in preclinical models.
Shipping seasonality can affect lyophilized cake integrity for CJC-1295 (no DAC); inspect vials after extreme transit delays even if COA predates shipment.
Training records for staff handling CJC-1295 (no DAC) should cover reconstitution math, RUO policy, and spill cleanup for research laboratories.
Network meta-analyses in Growth Research rarely include identical CJC-1295 (no DAC) specifications—match mg strength when citing external effect sizes.
CJC-1295 (no DAC) from Sulan Peptide Official is supplied for research use only (RUO)—not for human or veterinary use, diagnosis, or treatment. Direct specification or quotation questions via the Contact page or WhatsApp on sulanpeptide.shop.